Convergence Investment Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,158
Closed -$912K 281
2020
Q3
$912K Sell
4,158
-1,860
-31% -$394K 0.32% 117
2020
Q2
$1.15M Buy
6,018
+1,198
+25% +$210K 0.39% 82
2020
Q1
$747K Buy
+4,820
New +$561K 0.33% 99

Other funds holding TDOC

Convergence Investment Partners's TDOC Position: Q4 2020 in Review

Convergence Investment Partners sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 4,158 shares — an estimated $912K sold.

Convergence Investment Partners first reported a position in TDOC in Q1 2020 and held it in 3 quarters. The position peaked at $1.15M in Q2 2020. 900 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

  • Convergence Investment Partners reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
  • Convergence Investment Partners sold 4,158 Teladoc Health shares in Q4 2020, an estimated $912K.
  • Convergence Investment Partners first reported a position in Teladoc Health in Q1 2020 and held it in 3 quarters.
  • Convergence Investment Partners's Teladoc Health position peaked at $1.15M in Q2 2020.
  • 900 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Convergence Investment Partners's 13F filing for Q4 2020, filed 5 Feb 2021.